Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
ICU Medical, Inc. acquired from Pfizer in early 2017, Hospira Infusion Systems, the portion of Hospira dedicated to develop infusion pumps.
데이터 추가 비고
원인
Under certain cumulative conditions the time spent in each of the steps may deviate from the programmed time for the step. the infusion time will therefore be longer or shorter than the programmed time and the amount delivered at each step will also differ from the programmed amounts but the total volume of the infusion will be the same as programmed.